Dr. Egbelakin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 6th Ave
# MAIN3
Des Moines, IA 50314Phone+1 515-246-9320Fax+1 515-643-8966
Education & Training
- Indiana University School of MedicineResidency, Pediatrics, 2011 - 2014
- OtherClass of 2004
Certifications & Licensure
- MI State Medical License 2017 - 2027
- IA State Medical License 2014 - 2026
- WA State Medical License 2021 - 2026
- WV State Medical License 2024 - 2026
- GA State Medical License 2021 - 2025
- IN State Medical License 2017 - 2025
- MS State Medical License 2022 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hospital Medicine
- Join now to see all
Publications & Presentations
PubMed
- 108 citationsRisk factors for cisplatin‐associated ototoxicity in pediatric oncology patientsAllison M. Yancey, Michael S. Harris, Akinbode Egbelakin, Jaimie L. Gilbert, David B. Pisoni
Pediatric Blood & Cancer. 2012-07-15 - 141 citationsIncreased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemiaAkinbode Egbelakin, Michael J. Ferguson, Emily A. MacGill, Amalia S. Lehmann, Ariel R. Topletz
Pediatric Blood & Cancer. 2011-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: